Skip to content

Effect of different dose of nalbuphine combined with sufentanil for postoperative analgesia after laparoscopic hysterectomy: a randomized controlled trial.

Effect of different dose of nalbuphine combined with sufentanil for postoperative analgesia after laparoscopic hysterectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035409
Enrollment
Unknown
Registered
2020-08-10
Start date
2020-07-31
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

Group S:sufentanil 2.0µg/kg + granisetron 2mg + normal saline to 120ml
Group SN1:sufentanil 2.0µg/kg +nalbuphine 0.2 mg/kg + granisetron 2mg + normal saline to 120ml
Group SN2:sufentanil 2.0µg/kg +nalbuphine 0.4 mg/kg + granisetron 2mg + normal saline to 120ml
Group SN3:sufentanil 2.0µg/kg +nalbuphine 0.8 mg/kg + granisetron 2mg + normal saline to 120ml

Sponsors

Department of Anaesthesiology and Perioperative Medicine, The Second Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic hysterectomy; 2. ASA I-II; 3. Aged 40- 65 years; 4. BMI (Body Mass Index) 18.5~25 kg/m2; 5. With normal communication and certain learning ability; 6. Having signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Serious respiratory or circulatory diseases: such as severe atherosclerosis of coronary artery, cardiac failure, myocardial infarction, respiratory failure; 2. Neurological diseases: such as severe cerebral hemorrhage or cerebral infarction , hemiplegia or aphasia; 3. Mental illness: such as schizophrenia or depression; 4. Long-term abuse of drugs: including chemotherapy drugs and analgesics; 5. Obvious liver or kidney dysfunction; 6. Pregnant and lactating women; 7. Allergy to opioid.

Design outcomes

Primary

MeasureTime frame
VAS score;total PCIA and supplementary analgesia;post-operative quality of sleep;

Secondary

MeasureTime frame
Ramsay score;patients’ satisfaction;

Countries

China

Contacts

Public ContactXianwen Hu

The Second Hospital of Anhui Medical University

huxianwen001@126.com+86 17764433509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026